Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate

NCT01854736 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.

NCT NCT01854736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01854736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate
Lead sponsor
ALK-Abelló A/S
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2013
Completion date
December 31, 2015
Enrollment
51 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis due to grass pollens